Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial
Top Cited Papers
Open Access
- 4 June 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 35 (26), 1752-1759
- https://doi.org/10.1093/eurheartj/ehu209
Abstract
The aim of this study was to determine long-term results of renal artery denervation for treatment of treatment-resistant hypertension in the SYMPLICITY HTN-2 study. SYMPLICITY HTN-2 randomized 106 subjects with treatment-resistant hypertension to renal denervation or medical therapy alone. At 6 months, 37 control subjects crossed over to renal denervation. Office blood pressure measurements, antihypertensive medication use, and safety events were followed every 6 months through 3 years. Follow-up was available at 36 months in 40 of 52 subjects in the initial renal denervation group and at 30 months in 30 of 37 subjects who crossed over and received renal denervation at 6 months. Baseline blood pressure was 184 ± 19/99 ± 16 mmHg in all treated subjects. At 30-month post-procedure, systolic blood pressure decreased 34 mmHg (95% CI: −40, −27, P < 0.01) and diastolic blood pressure decreased 13 mmHg (95% CI: −16, −10, P < 0.01). The systolic and diastolic blood pressure reduction at 36 months for the initial renal denervation group was −33 mmHg (95% CI: −40, −25, P < 0.01) and −14 mmHg (95% CI: −17, −10, P < 0.01), respectively. Procedural complications included one haematoma, and one renal artery dissection before energy delivery that was treated successfully. Later complications included two cases of acute renal failure, which fully resolved, 15 hypertensive events requiring hospitalization, and three deaths. Renal denervation resulted in sustained lowering of blood pressure at 3 years in a selected population of subjects with severe, treatment-resistant hypertension without serious safety concerns. NCT00888433.Keywords
Funding Information
- NIH
This publication has 31 references indexed in Scilit:
- Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 studyThe Lancet, 2013
- Response and non-response to renal denervation: who is the ideal candidate?EuroIntervention, 2013
- Reversal of Genetic Salt-Sensitive Hypertension by Targeted Sympathetic AblationHypertension, 2013
- Neural Control of Renal FunctionComprehensive Physiology, 2011
- Assessment of Sympathetic Cardiovascular Drive in Human HypertensionHypertension, 2009
- Evaluation and Treatment of Resistant or Difficult-to-Control HypertensionThe Journal of Clinical Hypertension, 2008
- Blood Pressure in Adulthood and Life Expectancy With Cardiovascular Disease in Men and WomenHypertension, 2005
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999